Literature DB >> 16896665

Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion.

V Ambrosini1, M Farsad, C Nanni, R Schiavina, D Rubello, P Castellucci, E Pasquini, R Franchi, M Cavo, S Fanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16896665     DOI： 10.1007/s00259-006-0183-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.

Authors:  Mohsen Farsad; Riccardo Schiavina; Paolo Castellucci; Cristina Nanni; Barbara Corti; Giuseppe Martorana; Romeo Canini; Walter Grigioni; Stefano Boschi; Mario Marengo; Cinzia Pettinato; Eugenio Salizzoni; Nino Monetti; Roberto Franchi; Stefano Fanti
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

2.  Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Authors:  H Schirrmeister; M Bommer; A K Buck; S Müller; P Messer; D Bunjes; H Döhner; L Bergmann; S N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

3.  Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.

Authors:  Takako Yamaguchi; Jin Lee; Hiroji Uemura; Takeshi Sasaki; Nobukazu Takahashi; Takashi Oka; Kazuya Shizukuishi; Hisashi Endou; Yoshinobu Kubota; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-15       Impact factor: 9.236

4.  Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.

Authors:  Masafumi Nakamura; Hisashi Hasumi; Yasuhide Miyoshi; Shinpei Sugiura; Kiyoshi Fujinami; Masahiro Yao; Yoshinobu Kubota; Hiroji Uemura
Journal:  Int J Urol       Date:  2005-12       Impact factor: 3.369

5.  Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

Authors:  Martin Heinisch; Albert Dirisamer; Wolfgang Loidl; Franz Stoiber; Bernhard Gruy; Silke Haim; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488
  5 in total
  2 in total

1.  11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.

Authors:  Cristina Nanni; Elena Zamagni; Michele Cavo; Domenico Rubello; Paola Tacchetti; Cinzia Pettinato; Mohsen Farsad; Paolo Castellucci; Valentina Ambrosini; Gian Carlo Montini; Adil Al-Nahhas; Roberto Franchi; Stefano Fanti
Journal:  World J Surg Oncol       Date:  2007-06-20       Impact factor: 2.754

Review 2.  Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.